We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
SI - Site Forums : Silicon Investor - Welcome New SI Members!

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: SI Ron (Soup Nazi) who wrote (31484)1/23/2020 5:55:26 PM
From: 1Coffeehound2 Recommendations

Recommended By

  Read Replies (1) of 31692
If traders want to play RSLS, I wish them well, Ron; but here are some sobering facts for investors. Reshape LifeSciences began life as EnteroMedics (ETRM) which came public about a dozen years ago with an IPO of approximately 17 million shares. Since that time, there have been reverse splits of 1 for 6, 1 for 15, and 1 for 70 as ETRM then reverse splits of 1 for 15, 1 for 140, and 1 for 120 as RSLS. Taking the reverse splits out of the equation, this company would have issued not millions, not billions, not trillions, but QUADRILLIONS of shares since going public. Considering that, it should be of only minor concern to investors that a class action lawsuit has been filed against it; a lawsuit alleging misappropriation of trade secrets and infringement of two U.S. patents has been filed against it; three other lawsuits alleging breach of contract and other matters have been filed against it; and, of course, there is doubt about its ability to continue as a going concern.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext